Belmore Neidrauer LLP

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Silver - Firms: litigation

Independent boutique Belmore Neidrauer is home to a dedicated team of IP lawyers who boast a client-oriented approach and practical solutions. The set’s holistic services have been sought out by some of the biggest names in the pharmaceutical industry, including Pfizer and Janssen. Peter Wilcox has been lending his talents to both instructions, and he teamed up with Marian Wolanski to represent Janssen against Teva in one of the first patent infringement proceedings under the new PM(NOC) Regulations, involving its medication Invega Sustenna, which is used once a month to treat schizophrenia. This case is one of just a few in Canada in which the court upheld the validity of the patent relating to a dosage regimen. Stephanie Anderson partnered with Wilcox on the Pfizer mandate, successfully representing them in an EpiPen infringement action. The opposing party’s claims were determined to be invalid on several grounds, including overbreadth, and represents an important clarification of the law concerning overbreadth, which has often been questioned by academics.

Patent 1000 Analytics
Analytics and insights
Listings in
Recommended Individuals
In-depth analytics for law firm performance
Patent 1000 Analytics tracks the global legal industry to provide you accurate analysis of the firm's performance. Harness deep data, customizable tools and expert insight to guide strategy, streamline decision-making, and accelerate your business generation.

Unlock unlimited access to all IAM content